Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
Abstract
Inflammatory Bowel Disease is lifetime chronic progressive inflammatory disease. A considerable portion of patients, do not respond or lose response or experience side effect to “traditional” biological treatment such as anti-tumor necrosis factor (TNF)-α agents. The concept that the blockade of T cell traffic to the gut controls inflammation has stimulated the development of new drugs which selectively targets molecules involved in...
Paper Details
Title
Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
Published Date
May 23, 2019
Volume
25
Issue
1
Pages
19 - 24
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History